Cargando…
Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer
Background: Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to standard chemo- and radiotherapy. Recently, a new class of non-platinum-based halogenated molecules (called FMD compounds) was discovered that selectively kills cancer cells. Here, we investigate the potential of 1,2-Diamino-...
Autores principales: | Goetze, Robert G., Buchholz, Soeren M., Ou, Ning, Zhang, Qinrong, Patil, Shilpa, Schirmer, Markus, Singh, Shiv K., Ellenrieder, Volker, Hessmann, Elisabeth, Lu, Qing-Bin, Neesse, Albrecht |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627568/ https://www.ncbi.nlm.nih.gov/pubmed/31181844 http://dx.doi.org/10.3390/cells8060563 |
Ejemplares similares
-
Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas Cancer
por: Buchholz, Soeren M., et al.
Publicado: (2020) -
SPARC dependent collagen deposition and gemcitabine delivery in a genetically engineered mouse model of pancreas cancer
por: Ramu, Iswarya, et al.
Publicado: (2019) -
Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer
por: Patil, Shilpa, et al.
Publicado: (2021) -
TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer
por: Versemann, Lennart, et al.
Publicado: (2022) -
Activity of acute pancreatitis is modified by secreted protein acidic and rich in cysteine ablation
por: Ammer‐Herrmenau, Christoph, et al.
Publicado: (2022)